GSK PLC (GSK)
Clinical trial NCT06412120 updates: 1. start date: 2026-06-01 → 2026-08-01 2. completion date: 2031-06-01 → 2031-08-01 3. primary completion date: 2029-06-01 → 2029-08-01
Clinical trial NCT06412120 updates: 1. start date: 2026-06-01 → 2026-08-01 2. completion date: 2031-06-01 → 2031-08-01 3. primary completion date: 2029-06-01 → 2029-08-01
Clinical trial NCT06957431 updates: 1. completion date: 2033-10-31 → 2036-04-30 2. primary completion date: 2028-11-30 → 2031-05-31
Clinical trial NCT07489573 updates: 1. status: NOT_YET_RECRUITING → RECRUITING 2. start date: 2026-08-21 → 2026-06-01
Clinical trial NCT05349214: completion date: 2027-05-13 → 2027-04-17.
Clinical trial NCT06744335 updates: 1. status: RECRUITING → ACTIVE_NOT_RECRUITING 2. enrollment: 1282 → 1283 participants 3. enrollment type: ESTIMATED → ACTUAL
Clinical trial NCT00911560 updates: 1. completion date: 2026-05-01 → 2027-05-01 2. primary completion date: 2026-05-01 → 2027-05-01
Clinical trial NCT03881098: status: RECRUITING → ACTIVE_NOT_RECRUITING.
Clinical trial NCT04753879 updates: 1. completion date: 2029-12-01 → 2026-07-01 2. primary completion date: 2026-12-01 → 2026-07-01
Clinical trial NCT05523440: enrollment: 7 → 9 participants.
Clinical trial NCT07332442: start date: 2026-05-01 → 2026-05-18.